| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |